205 related articles for article (PubMed ID: 12969373)
1. Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response.
Harris J; Werling D
Cell Microbiol; 2003 Oct; 5(10):671-80. PubMed ID: 12969373
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the host immune response by respiratory syncytial virus proteins.
Schmidt ME; Varga SM
J Microbiol; 2017 Mar; 55(3):161-171. PubMed ID: 28243940
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus--viral biology and the host response.
Hacking D; Hull J
J Infect; 2002 Jul; 45(1):18-24. PubMed ID: 12217726
[TBL] [Abstract][Full Text] [Related]
4. Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.
Descamps D; Peres de Oliveira A; Gonnin L; Madrières S; Fix J; Drajac C; Marquant Q; Bouguyon E; Pietralunga V; Iha H; Morais Ventura A; Tangy F; Vidalain PO; Eléouët JF; Galloux M
J Virol; 2021 Oct; 95(22):e0091221. PubMed ID: 34431698
[TBL] [Abstract][Full Text] [Related]
5. Innate immune responses in respiratory syncytial virus infections.
Krishnan S; Halonen M; Welliver RC
Viral Immunol; 2004; 17(2):220-33. PubMed ID: 15279701
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses.
Chirkova T; Boyoglu-Barnum S; Gaston KA; Malik FM; Trau SP; Oomens AG; Anderson LJ
J Virol; 2013 Dec; 87(24):13466-79. PubMed ID: 24089561
[TBL] [Abstract][Full Text] [Related]
7. Human Respiratory Syncytial Virus: An Introduction.
Jorquera PA; Anderson L; Tripp RA
Methods Mol Biol; 2016; 1442():1-12. PubMed ID: 27464683
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.
Canedo-Marroquín G; Acevedo-Acevedo O; Rey-Jurado E; Saavedra JM; Lay MK; Bueno SM; Riedel CA; Kalergis AM
Front Cell Infect Microbiol; 2017; 7():367. PubMed ID: 28861397
[TBL] [Abstract][Full Text] [Related]
9. Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches.
Taleb SA; Al Thani AA; Al Ansari K; Yassine HM
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1817-1827. PubMed ID: 29876771
[TBL] [Abstract][Full Text] [Related]
10. Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.
Villenave R; Broadbent L; Douglas I; Lyons JD; Coyle PV; Teng MN; Tripp RA; Heaney LG; Shields MD; Power UF
J Virol; 2015 Dec; 89(24):12309-18. PubMed ID: 26423940
[TBL] [Abstract][Full Text] [Related]
11. Autophagy, TGF-β, and SMAD-2/3 Signaling Regulates Interferon-β Response in Respiratory Syncytial Virus Infected Macrophages.
Pokharel SM; Shil NK; Bose S
Front Cell Infect Microbiol; 2016; 6():174. PubMed ID: 28018859
[TBL] [Abstract][Full Text] [Related]
12. The alpha-1 subunit of the Na+,K+-ATPase (ATP1A1) is required for macropinocytic entry of respiratory syncytial virus (RSV) in human respiratory epithelial cells.
Lingemann M; McCarty T; Liu X; Buchholz UJ; Surman S; Martin SE; Collins PL; Munir S
PLoS Pathog; 2019 Aug; 15(8):e1007963. PubMed ID: 31381610
[TBL] [Abstract][Full Text] [Related]
13. The adaptive immune response to respiratory syncytial virus.
Varga SM; Braciale TJ
Curr Top Microbiol Immunol; 2013; 372():155-71. PubMed ID: 24362689
[TBL] [Abstract][Full Text] [Related]
14. New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus.
Lay MK; Bueno SM; Gálvez N; Riedel CA; Kalergis AM
Crit Rev Microbiol; 2016 Sep; 42(5):800-12. PubMed ID: 26119025
[TBL] [Abstract][Full Text] [Related]
15. Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans.
Sun Y; Jain D; Koziol-White CJ; Genoyer E; Gilbert M; Tapia K; Panettieri RA; Hodinka RL; López CB
PLoS Pathog; 2015 Sep; 11(9):e1005122. PubMed ID: 26336095
[TBL] [Abstract][Full Text] [Related]
16. Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells.
Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zhang XJ; Zheng YB; Zheng YP; Hong T; He JS
Int Immunopharmacol; 2017 May; 46():62-69. PubMed ID: 28259002
[TBL] [Abstract][Full Text] [Related]
17. Innate immune responses to respiratory syncytial virus infection.
Mukherjee S; Lukacs NW
Curr Top Microbiol Immunol; 2013; 372():139-54. PubMed ID: 24362688
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses.
Sedeyn K; Schepens B; Saelens X
PLoS Pathog; 2019 Oct; 15(10):e1007984. PubMed ID: 31622448
[TBL] [Abstract][Full Text] [Related]
19. Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression.
Farrag MA; Almajhdi FN
Viral Immunol; 2016; 29(1):11-26. PubMed ID: 26679242
[TBL] [Abstract][Full Text] [Related]
20. The innate immune response to RSV: Advances in our understanding of critical viral and host factors.
Sun Y; López CB
Vaccine; 2017 Jan; 35(3):481-488. PubMed ID: 27686836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
